Schizoaffective Disorders Completed Phase 2 Trials for Risperidone (DB00734)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01450514POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic SchizophreniaTreatment